出处
《广州医学院学报》
2006年第2期64-68,共5页
Academic Journal of Guangzhou Medical College
基金
广东省科技计划项目(2004B338010114)
参考文献20
-
1Ralevic V, Burnstock G. Receptors for purines and pyrimidines [ J ]. Pharmacological Reviews, 1998, 50 ( 3 ) : 413- 492.
-
2Ferre S, Fredholm BB, Morelli M, et al. Adenosine-dopamine receptor-receptor interaction as an intergratie mechanism in the basal ganglia [ J ]. Trends Neurosci, 1997,20(10) :482 -487.
-
3Lee YC, Chien CL, Sun CN, et al. Characterization of the rat A2A adenosine receptor gene : a 4.8 - kb promoter-proximal DNA fragment confers selective expression in the central nervous system [ J ]. European J Neuroscience, 2003, 18(7):1786 - 1796.
-
4Braak H, Rub U, Braak E. Neuroanatomy of Parkinson disease. Changes in the neuronal cytoskeleton of a few disease-susceptible types of neurons lead to progressive destruction of circumscribed areas in the limbic and motor systems [ J ].Nervenarzt, 2000, 71 (6):459-469.
-
5Aoyama S, Kase H, Borrelli E. Rescue of Locomotor Impairment in Dopamine D2 Receptor-Deficient Mice by an Adenosine A2A Receptor Antagonist[ J ]. The Journal of Neuroscience, 2000, 20(15) :5848 - 58
-
6Hillion J, Canals M, Torvinen M, et al. Coaggregation,cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors [ J ]. J Biol Chem,2002,277(20) : 18091 - 18097
-
7Nishi A, Liu F, Matsuyama S, et al. Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling [ J ]. Proc Natl Acad Sci U S A,2003, 100(3) : 1322 -1327.
-
8Pintor A, Pezzola A, Reggio R, et al. The mGlu5 receptor agonist CHPG stimulates striatal glutamate release: possible involvement of A2A receptors [ J ]. Neuroreport, 11 (16) :3611 - 3614.
-
9Popoli P, Pezzola A, Torvinen M, et al. The selective mGlu (5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D( 2 ) receptors in the rat striatum: interactions with adenosine A (2a)receptors [ J ]. Neuropsychopharmacology, 2001, 25 (4) :505 -513.
-
10Coccurello R, Breysse N, Amalric M. Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats [ J ]. Neuropsychopharmacology, 2004,29(8):1451 - 1461.
同被引文献3
-
1张锦明,田嘉禾,王武尚,刘伯里.在线制备^(11)C-Triflate-CH_3[J].同位素,2006,19(2):124-128. 被引量：21
-
2王瑞民,王庆胜,郭喆,张锦明,尚爱加,姚树林,田嘉禾.多巴胺转运蛋白PET成像在建立帕金森病大鼠模型中的作用[J].中国医学影像学杂志,2008,16(1):1-4. 被引量：1
-
3张锦明,张晓军,李云钢,刘健,徐白萱,王瑞民,田嘉禾.自动化合成^(11)C-Raclopride及质量控制[J].同位素,2014,27(4):230-235. 被引量：2
-
1潘家祜,张磊.腺苷A_(2A)受体拮抗剂——一种治疗帕金森症的新手段[J].中国临床药学杂志,1998,7(6):313-316.
-
2张士国.“网络成瘾诊断标准”争议中前行[J].大众健康,2009(1):22-24.
-
3宋璐,马雅萍,刘振国,巴茂文.腺苷A2A受体拮抗剂改善帕金森病运动并发症[J].中华神经科杂志,2008,41(12):843-847. 被引量：3
-
4用胰岛素会“上瘾”吗[J].医药保健杂志,2008(15):62-62.
-
5王恒会,罗蔚锋.腺苷A_(2A)受体拮抗剂治疗帕金森病的研究进展[J].国外医学（老年医学分册）,2006,27(6):244-247. 被引量：3
-
6徐永川,冯涓,韩东.急性脑梗死血小板数量与血小板平均体积的关系[J].中风与神经疾病杂志,2011,28(10):942-943. 被引量：4
-
7赵颖琳,许崇涛.腺苷及其受体在睡眠剥夺快速抗抑郁效应机制中的研究进展[J].国际精神病学杂志,2010,37(2):89-92. 被引量：2
-
8章杰,许崇涛.腺苷与精神分裂症[J].中国行为医学科学,2008,17(4):382-384. 被引量：1
-
9菊轩,许崇涛.快眼动睡眠剥夺及腺苷受体拮抗剂对抑郁模型大鼠自发活动的影响[J].浙江临床医学,2015,17(12):2059-2061.
-
10陈梦千,夏宏运,林彬,刘幼兰,郭吴珉.食物上瘾现象及其调控机理的研究[J].中国科技博览,2014(32):335-335.
